Elixinol Wellness (ASX:EXL) — Material Events
ASX:EXL · 12 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Elixinol’s Q4 Surge – Revenue Up, Costs Down, Cash Flow Turns PositiveMedium
Elixinol reports revenue growth, cost cuts, and first positive operating cash flow in Q4 FY25
29 Jan 2026
·Quarterly Activity Report and Appendix 4C
·85
Elixinol Secures $2.5M Placement, Taps Gavin Evans to Accelerate ProfitabilityMedium
Elixinol Raises $2.5M Placement, Appoints Strategic Advisor to Drive Profitability
8 Sept 2025
·Capital Raising
·80
Elixinol Wellness Drives Growth with Cost Cuts and New Leadership in FY25Medium
Elixinol Wellness posts Q4 FY25 revenue growth, cost cuts, and positive cash flow; new leadership drives FY26 growth strategy
12 Feb 2026
·Investor Presentation
·75
Elixinol Strengthens Balance Sheet with Revised Healthy Chef DealMedium
Elixinol revises Healthy Chef acquisition terms, boosts balance sheet and growth focus on Australia
18 Dec 2025
·ASX Announcement
·Unexpected
·75
Elixinol Wellness Rebounds in Q2 with Strategic Cost Cuts and New Product LaunchMedium
Elixinol Wellness Q2 2025 revenue rebounds, cost cuts underway, funding secured for profit push
31 July 2025
·Quarterly Activities Report & Appendix 4C
·75
Elixinol Unveils Protein Water Range to Tap $499M Australian MarketMedium
Elixinol launches Healthy Chef Protein Water range to enter booming Australian protein market
20 Aug 2025
·Product Launch Announcement
·75
Elixinol Sustains Margin Gains and Cash Flow Momentum in Q1 FY26Medium
Elixinol posts stable revenue, improved margins, and positive cash flow in Q1 FY26
21 Apr 2026
·Quarterly Activity Report and Appendix 4C
·75
Elixinol Wellness Boosts Margins Amid Strategic Cost Cuts and Capital RaiseMedium
Elixinol Wellness Q3 revenue steady, margin up 300bps; $2.5M capital raise supports growth and cost cuts
31 Oct 2025
·Quarterly Activities Report & Appendix 4C
·75
Elixinol Boosts Revenue and Margins Despite Integration CostsMedium
Elixinol posts 12.8% revenue growth and margin gains amid integration costs in H1 2025
29 Aug 2025
·Interim Financial Results
·70
Elixinol Wellness Unveils 220 Million Options Offer Ahead of Shareholder VoteMedium
Elixinol Wellness launches 220 million option offer to placement investors, subject to shareholder approval
30 Oct 2025
·Prospectus
·70
Elixinol’s Revenue Climbs 12.8% as Profitability Target Looms in Q4Medium
Elixinol posts 12.8% revenue growth in H1 2025, targets profitability by Q4
29 Aug 2025
·Results Presentation
·70
No articles in this tier for the last 12 months.